References
- Bollag W., Lefrancq H. Perspectives d'avenir des rétinoides. Journal de Médecine Esthétique et de Chirurgie Dermatologique 1986; 13(52)269–273
- Brindley C. J. Overview of recent clinical pharmacokinetic studies with acitretin (Ro 10–1670, etretin). Dermatologica 1989; 178: 79–87
- Caldwell J. Conjugation of xenobiotic carboxylic acids. Metabolic Basis of Detoxication, Metabolism of Functional Groups, W. B. Jacoby, J. R. Bend, J. Caldwell. Academic Press, New York 1982; 271–290
- Chou R. C., Wyss R., Huselton C. A., Wiegand U.-W. A newly discovered xenobiotic metabolic pathway: ethyl ester formation. Life Sciences 1991; 49(21)PL169–172
- Di Giovanna J. J., Zech L. A., Ruddel H. E., Gantt G., Peck G. L. Etretinate: persistent serum levels after long-term therapy. Archives of Dermatology 1989; 125: 246–251
- Geiger J.-M., Czarnetzki B. Acitretin (Ro 10–1670, etretin): overall evaluation of clinical studies. Dermatologica 1988; 176: 182–190
- Geiger J.-M., Brindley C. J. Cis-trans interconversion of acitretin in man. Skin Pharmacology 1988; 1: 230–236
- Hearn W. L., Flynn D. D., Hime G. W., Rose S., Cofino J. C., Mantero-Atienza E., Wetli C. V., Mash D. C. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. Journal of Neurochemistry 1991; 56: 698–701
- Huselton C. A., Fayer B. E., Carland W. A., Liberato D. J. Quantification of endogenous retinoic acid in human plasma by liquid chromatography/mass spectrometry. Liquid Chromatography/Mass Spectrometry: Applications in Agricultural, Pharmaceutical and Environmental Chemistry, M. A. Brown. ACS Symposium Series 420, American Chemical Society, Washington, DC 1990; 166–178
- Kistler A. Structure-activity relationship of retinoids on the differentiation of cultured chick foot skin. Roux's Archives of Developmental Biology 1984; 194: 9–17
- Kistler A. Structure-activity relationship of retinoids in fetal rat bone cultures. Calcified Tissue International 1981; 33: 249–254
- Massarella J., Vane F., Bugge C., Rodriguez L., Cunningham W. J., Franz T., Colburn W. Etretinate kinetics during chronic dosing in severe psoriasis. Clinical Pharmacology and Therapeutics 1985; 37: 439–446
- Miller D. A., De Luca H. F. Activation of retinoic acid by coenzyme A, for the formation of ethyl retinoate. Proceedings of the National Academy of Sciences 1985; 82: 6419–6422
- Rollman O., Vahlquist A. Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate. British Journal of Dermatology 1983; 109: 439–447
- Vahlquist A., Rollman O., Pihl-Lundin I. Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases; drug accumulation in adrenals and fat. Acta Dermato-Venereologica 1986; 66: 431–434
- Wiegand U.-W., Jensen B. K. GenevaSwitzerland 1990, Symposium presentation. Retinoids: 10 years on, 15–18 November
- Wiegand U.-W., Jensen B. K. Pharmacokinetics of acitretin in humans. Retinoids: 10 Years on, J.-H. Saurat. Karger, Basel 1991; 192–203
- Wyss R., Bucheli F. Quantitative analysis of retinoids in biological fluids by high performance liquid chromatography using column switching. II. Simultaneous determination of etretinate, acitretin and 13-cis-acitretin in plasma. Journal of Chromatography (Biomedical Applications) 1988; 431: 297–307
- Wyss R., Bucheli F. Use of direct injection precolumn techniques for the high-performance liquid chromatographic determination of the retinoids acitretin and 13-cis-acitrein in plasma. Journal of Chromatography 1992; 593: 55–62